Literature DB >> 9880514

Interaction between CD45-AP and protein-tyrosine kinases involved in T cell receptor signaling.

S Motoya1, K Kitamura, A Matsuda, A L Maizel, H Yamamoto, A Takeda.   

Abstract

CD45-AP associates specifically with CD45, a protein-tyrosine phosphatase essential for antigen receptor-mediated signal transduction. CD45 modulates the activity of Src family protein-tyrosine kinases involved at the onset of antigen receptor-mediated signaling by dephosphorylating their regulatory tyrosyl residues. We have shown that lymphocyte responses to antigen receptor stimulation are impaired in CD45-AP-null mice. To examine the possibility that CD45-AP coordinates the interaction between CD45 and its substrates, we investigated the associations of CD45-AP with several protein-tyrosine kinases. Endogenous CD45-AP coimmunoprecipitated with Lck and ZAP-70 in both CD45-positive T cells and their CD45-negative variants after stimulation by antigen receptor ligation. Concomitantly, CD45 coimmunoprecipitated with Lck and ZAP-70 after T cell receptor-mediated stimulation of CD45-positive cells. Recombinant CD45-AP exhibited specific binding to Lck and ZAP-70 protein-tyrosine kinases, but not to Fyn or Csk, in lysates of both CD45-positive and -negative T cells. Specific interactions were demonstrated between the respective recombinant proteins as well. These results demonstrate that CD45-AP associates directly and selectively with Lck and ZAP-70 in response to T cell receptor-mediated stimulation. The associations of CD45-AP with Lck and ZAP-70 may mediate the functional interactions of these kinases with CD45 during antigen receptor stimulation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9880514     DOI: 10.1074/jbc.274.3.1407

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  A regulatory polymorphism at position -309 in PTPRCAP is associated with susceptibility to diffuse-type gastric cancer and gene expression.

Authors:  Hyoungseok Ju; Byungho Lim; Minjin Kim; Yong Sung Kim; Woo Ho Kim; Chunhwa Ihm; Seung-Moo Noh; Dong Soo Han; Hang-Jong Yu; Bo Youl Choi; Changwon Kang
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

Review 2.  Lessons learned from gene expression profiling of cutaneous T-cell lymphoma.

Authors:  B O Dulmage; L J Geskin
Journal:  Br J Dermatol       Date:  2013-12       Impact factor: 9.302

3.  CD45-associated protein promotes the response of primary CD4 T cells to low-potency T-cell receptor (TCR) stimulation and facilitates CD45 association with CD3/TCR and lck.

Authors:  David Leitenberg; Rustom Falahati; Dan Dan Lu; Akiko Takeda
Journal:  Immunology       Date:  2007-04-12       Impact factor: 7.397

4.  Distinct Transcriptomic Features are Associated with Transitional and Mature B-Cell Populations in the Mouse Spleen.

Authors:  Eden Kleiman; Daria Salyakina; Magali De Heusch; Kristen L Hoek; Joan M Llanes; Iris Castro; Jacqueline A Wright; Emily S Clark; Derek M Dykxhoorn; Enrico Capobianco; Akiko Takeda; Jean-Christophe Renauld; Wasif N Khan
Journal:  Front Immunol       Date:  2015-02-11       Impact factor: 7.561

5.  Prognostic significance of X-ray cross-complementing gene 1 expression in gastric cancer.

Authors:  Jian Wang; Tongshan Wang; Jun Xu; WenJiao Chen; Wei Shi; Jianfeng Cheng; Ping Liu; Xiqiao Zhou
Journal:  Chin J Cancer Res       Date:  2016-06       Impact factor: 5.087

6.  Lymphocyte phosphatase-associated phosphoprotein proteoforms analyzed using monoclonal antibodies.

Authors:  Alexander Filatov; Natalia Kruglova; Tatiana Meshkova; Dmitriy Mazurov
Journal:  Clin Transl Immunology       Date:  2015-10-09

7.  Constitutive and activation-dependent phosphorylation of lymphocyte phosphatase-associated phosphoprotein (LPAP).

Authors:  Natalia A Kruglova; Tatiana D Meshkova; Arthur T Kopylov; Dmitriy V Mazurov; Alexander V Filatov
Journal:  PLoS One       Date:  2017-08-21       Impact factor: 3.240

8.  C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive disease.

Authors:  Johannes Landskron; Sigrid M Kraggerud; Elisabeth Wik; Anne Dørum; Merete Bjørnslett; Espen Melum; Øystein Helland; Line Bjørge; Ragnhild A Lothe; Helga B Salvesen; Kjetil Taskén
Journal:  PLoS One       Date:  2017-07-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.